Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain

Details for Australian Patent Application No. 2004286819 (hide)

Owner Celgene Corporation

Inventors Faleck, Herbert; Zeldis, Jerome B.; Manning, Donald C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004286819

PCT Pub. Number WO2005/043971

Priority 10/693,794 23.10.03 US

Filing date 23 April 2004

Wipo publication date 19 May 2005

International Classifications

A01N 43/42 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 43/38 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 43/90 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds - having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/47 (2006.01) - Quinolines

A61K 31/52 (2006.01)

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/043971 Priority application(s): WO2005/043971

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004286823-Composition and method for treating macular degeneration

2004286818-Methods for treatment, modification and management of pain using 1-oxo-2-(2,-6-Dioxopiperidin-3-YL)-4-M ethylisoindoline